{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:05Z","timestamp":1790812805529,"version":"4.1.0"},"reference-count":30,"publisher":"Frontiers Media SA","content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"DOI":"10.3389\/fmed.2017.00092","type":"journal-article","created":{"date-parts":[[2017,6,27]],"date-time":"2017-06-27T03:45:49Z","timestamp":1498535149000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["Multiple Myeloma Cells Express Key Immunoregulatory Cytokines and Modulate the Monocyte Migratory Response"],"prefix":"10.3389","volume":"4","author":[{"given":"Leonardo","family":"Freire-de-Lima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Fl\u00e1via Fernandes Ribas","family":"Nardy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erivan Schnaider","family":"Ramos-Junior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciana","family":"Conde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9ssica","family":"Santos Lemos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo Marques da","family":"Fonseca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana Echevarria","family":"Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Maiolino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Morrot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2017,6,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1002\/ajh.23810","article-title":"Multiple myeloma: 2014 Update on diagnosis, risk-stratification, and management","volume":"89","author":"Vincent Rajkumar","year":"2014","journal-title":"Am J Hematol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1007\/s00774-009-0154-7","article-title":"Targeting the bone microenvironment in multiple myeloma","volume":"28","author":"Roodman","year":"2010","journal-title":"J Bone Miner Metab"},{"key":"B3","doi-asserted-by":"publisher","first-page":"163","DOI":"10.3324\/haematol.2013.090977","article-title":"Myeloma plasma cells alter the bone marrow microenvironment by stimulating the proliferation of mesenchymal stromal cells","volume":"99","author":"Noll","year":"2014","journal-title":"Haematologica"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-017-1992-0","article-title":"Bone marrow myeloid cells in regulation of multiple myeloma progression","author":"Herlihy","year":"2017","journal-title":"Cancer Immunol Immunother"},{"key":"B5","doi-asserted-by":"publisher","first-page":"4766","DOI":"10.1158\/0008-5472.CAN-15-1320","article-title":"Multiple myeloma impairs bone marrow localization of effector natural killer cells by altering the chemokine microenvironment","volume":"75","author":"Ponzetta","year":"2015","journal-title":"Cancer Res"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1182\/blood-2015-01-623975","article-title":"Dendritic cells accumulate in the bone marrow of myeloma patients where they protect tumor plasma cells from CD8+ T-cell killing","volume":"126","author":"Leone","year":"2015","journal-title":"Blood"},{"key":"B7","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1038\/nature06175","article-title":"Taking dendritic cells into medicine","volume":"449","author":"Steinman","year":"2007","journal-title":"Nature"},{"key":"B8","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1126\/science.1170540","article-title":"In vivo analysis of dendritic cell development and homeostasis","volume":"324","author":"Liu","year":"2009","journal-title":"Science"},{"key":"B9","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/S0145-2126(99)90169-8","article-title":"Malignant hematopoietic cell lines: in vitro models for the study of multiple myeloma and plasma cell leukemia","volume":"24","author":"Drexler","year":"2000","journal-title":"Leuk Res"},{"key":"B10","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/j.exphem.2010.06.012","article-title":"The cytokine\/chemokine pattern in the bone marrow environment of multiple myeloma patients","volume":"38","author":"Cao","year":"2010","journal-title":"Exp Hematol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"776","DOI":"10.3324\/haematol.2009.015628","article-title":"Hypoxia-inducible factor-2 is a novel regulator of aberrant CXCL12 expression in multiple myeloma plasma cells","volume":"95","author":"Martin","year":"2010","journal-title":"Haematologica"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.17353","article-title":"Expression and release of glucose-regulated protein-78 (GRP78) in multiple myeloma","author":"Steiner","year":"2017","journal-title":"Oncotarget"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.14707","article-title":"Epigenetic repression of miR-375 is the dominant mechanism for constitutive activation of the PDPK1\/RPS6KA3 signalling axis in multiple myeloma","author":"Tatekawa","year":"2017","journal-title":"Br J Haematol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1186\/s12967-016-1100-9","article-title":"LncRNA MALAT1 promotes development of mantle cell lymphoma by associating with EZH2","volume":"14","author":"Wang","year":"2016","journal-title":"J Transl Med"},{"key":"B15","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.7150\/thno.15584","article-title":"Lycorine downregulates HMGB1 to inhibit autophagy and enhances bortezomib activity in multiple myeloma","volume":"6","author":"Roy","year":"2016","journal-title":"Theranostics"},{"key":"B16","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1002\/gcc.20404","article-title":"Molecular characterization of human multiple myeloma cell lines by integrative genomics: insights into the biology of the disease","volume":"46","author":"Lombardi","year":"2007","journal-title":"Genes Chromosomes Cancer"},{"key":"B17","doi-asserted-by":"publisher","first-page":"3148","DOI":"10.1182\/blood-2003-06-1984","article-title":"BAFF and APRIL protect myeloma cells from apoptosis induced by interleukin 6 deprivation and dexamethasone","volume":"103","author":"Moreaux","year":"2004","journal-title":"Blood"},{"key":"B18","doi-asserted-by":"publisher","first-page":"e60671","DOI":"10.1371\/journal.pone.0060671","article-title":"Characterization of the toll-like receptor expression profile in human multiple myeloma cells","volume":"8","author":"Abdi","year":"2013","journal-title":"PLoS One"},{"key":"B19","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.ejca.2012.05.005","article-title":"A review on CXCR4\/CXCL12 axis in oncology: no place to hide","volume":"49","author":"Domanska","year":"2013","journal-title":"Eur J Cancer"},{"key":"B20","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1111\/cei.12579","article-title":"CXCL10 induces the recruitment of monocyte-derived macrophages into kidney, which aggravate puromycin aminonucleoside nephrosis","volume":"180","author":"Petrovic-Djergovic","year":"2015","journal-title":"Clin Exp Immunol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1002\/eji.1830250113","article-title":"Actions of the chemotactic cytokines MCP-1, MCP-2, MCP-3, RANTES, MIP-1 alpha and MIP-1 beta on human monocytes","volume":"25","author":"Uguccioni","year":"1995","journal-title":"Eur J Immunol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"292376","DOI":"10.1155\/2014\/292376","article-title":"The inflammatory chemokine CCL5 and cancer progression","volume":"2014","author":"Aldinucci","year":"2014","journal-title":"Mediators Inflamm"},{"key":"B23","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/nri3175","article-title":"Coordinated regulation of myeloid cells by tumours","volume":"12","author":"Gabrilovich","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1111\/j.1365-3083.2010.02463.x","article-title":"Increased level of both CD4+FOXP3+ regulatory T cells and CD14+HLA-DR(-)\/low myeloid-derived suppressor cells and decreased level of dendritic cells in patients with multiple myeloma","volume":"72","author":"Brimnes","year":"2010","journal-title":"Scand J Immunol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.cccn.2004.05.025","article-title":"Clinical significance of circulating endothelial adhesion molecules (sE-selectin and sICAM) in untreated multiple myeloma patients","volume":"349","author":"Alexandrakis","year":"2004","journal-title":"Clin Chim Acta"},{"key":"B26","doi-asserted-by":"crossref","first-page":"7224","DOI":"10.4049\/jimmunol.151.12.7224","article-title":"Soluble intercellular adhesion molecule-1 inhibits MHC-restricted specific T cell\/tumor interaction","volume":"151","author":"Becker","year":"1993","journal-title":"J Immunol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1002\/ccr3.76","article-title":"Long-term survival in multiple myeloma","volume":"2","author":"Jo\u00e3o","year":"2014","journal-title":"Clin Case Rep"},{"key":"B28","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1111\/bjh.13537","article-title":"Trends in survival of multiple myeloma patients in Germany and the United States in the first decade of the 21st century","volume":"171","author":"Pulte","year":"2015","journal-title":"Br J Haematol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1159\/000357394","article-title":"Survival of multiple myeloma patients aged 65-70 years in the era of novel agents and autologous stem cell transplantation. A multicenter retrospective collaborative study of the Japanese Society of Myeloma and the European Myeloma Network","volume":"132","author":"Ozaki","year":"2014","journal-title":"Acta Haematol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1200\/JCO.2006.09.0100","article-title":"Patterns of survival in multiple myeloma: a population-based study of patients diagnosed in Sweden from 1973 to 2003","volume":"25","author":"Kristinsson","year":"2007","journal-title":"J Clin Oncol"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fmed.2017.00092\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T05:06:04Z","timestamp":1692853564000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fmed.2017.00092\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,27]]},"references-count":30,"alternative-id":["10.3389\/fmed.2017.00092"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2017.00092","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,27]]},"article-number":"92"}}